SE9603466D0 - New compounds - Google Patents

New compounds

Info

Publication number
SE9603466D0
SE9603466D0 SE9603466A SE9603466A SE9603466D0 SE 9603466 D0 SE9603466 D0 SE 9603466D0 SE 9603466 A SE9603466 A SE 9603466A SE 9603466 A SE9603466 A SE 9603466A SE 9603466 D0 SE9603466 D0 SE 9603466D0
Authority
SE
Sweden
Prior art keywords
new compounds
peptides
heterodimers
absorbable
cys
Prior art date
Application number
SE9603466A
Other languages
English (en)
Swedish (sv)
Inventor
Haakan Bergstrand
Tomas Eriksson
Magnus Lindvall
Bengt Saernstrand
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9603466A priority Critical patent/SE9603466D0/xx
Publication of SE9603466D0 publication Critical patent/SE9603466D0/xx
Priority to PCT/SE1997/001552 priority patent/WO1998012213A2/en
Priority to AU44061/97A priority patent/AU4406197A/en
Priority to ZA9708477A priority patent/ZA978477B/xx
Priority to ARP970104369A priority patent/AR009805A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1021—Tetrapeptides with the first amino acid being acidic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
SE9603466A 1996-09-23 1996-09-23 New compounds SE9603466D0 (sv)

Priority Applications (5)

Application Number Priority Date Filing Date Title
SE9603466A SE9603466D0 (sv) 1996-09-23 1996-09-23 New compounds
PCT/SE1997/001552 WO1998012213A2 (en) 1996-09-23 1997-09-15 Cysteine containing peptides
AU44061/97A AU4406197A (en) 1996-09-23 1997-09-15 Cysteine containing peptides
ZA9708477A ZA978477B (en) 1996-09-23 1997-09-19 Cysteine containing peptides.
ARP970104369A AR009805A1 (es) 1996-09-23 1997-09-23 Peptidos que contienen cisteina

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9603466A SE9603466D0 (sv) 1996-09-23 1996-09-23 New compounds

Publications (1)

Publication Number Publication Date
SE9603466D0 true SE9603466D0 (sv) 1996-09-23

Family

ID=20403988

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9603466A SE9603466D0 (sv) 1996-09-23 1996-09-23 New compounds

Country Status (5)

Country Link
AR (1) AR009805A1 (es)
AU (1) AU4406197A (es)
SE (1) SE9603466D0 (es)
WO (1) WO1998012213A2 (es)
ZA (1) ZA978477B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4674231B2 (ja) 2004-03-01 2011-04-20 ボード・オブ・リージエンツ，ザ・ユニバーシテイ・オブ・テキサス・システム ２量体小分子アポトーシス増強剤
MX2009010667A (es) * 2007-04-12 2010-02-24 Joyant Pharmaceuticals Inc Dimeros y trimeros mimeticos de smac utiles como agentes anti-cancer.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0142387A1 (en) * 1983-08-26 1985-05-22 Anda Biologicals Process for the preparation of vaccines specific for LH and HCG and process for their detection
US5270170A (en) * 1991-10-16 1993-12-14 Affymax Technologies N.V. Peptide library and screening method
ES2142867T3 (es) * 1992-04-13 2000-05-01 Oklahoma Med Res Found Procedimientos y reactivos para el diagnostico de autoanticuerpos.
CA2144180A1 (en) * 1992-09-08 1994-03-17 George A. Heavner Peptide inhibitors of cellular adhesion
SE9403526D0 (sv) * 1994-10-14 1994-10-14 Astra Ab New Peptides
WO1996013589A1 (en) * 1994-10-27 1996-05-09 Immulogic Pharmaceutical Corporation T cell epitopes of the major allergens from ambrosia artemisiifolia
EP0923604A1 (en) * 1996-04-12 1999-06-23 Astra Aktiebolag Cysteine-containing or methioine-containing peptides with immunomodulatory effects

Also Published As

Publication number Publication date
ZA978477B (en) 1998-03-23
WO1998012213A2 (en) 1998-03-26
WO1998012213A3 (en) 1998-04-30
AU4406197A (en) 1998-04-14
AR009805A1 (es) 2000-05-03

Similar Documents

Publication Publication Date Title
IL105554A0 (en) Peptides of human papilloma virus for use in human t cell response inducing compositions
EP2327712A3 (en) Treatment of autoimmune conditions with copolymer 1 and related copolymers and peptides
NO920252L (no) T celle-reseptor peptider som terapeutiske midler for autoimmune og maligne sykdommer
DK0643726T3 (da) Peptider af humant p53-protein til anvendelse i sammensætninger, som inducerer humant T-celle-respons, og humane p53-protei
RS51157B (sr) Baff receptor (bcma), imunoregulatorni agens
DE69126568D1 (de) Neues physiologisch aktives Schweinepeptid (CNP-53)
BR9607336A (pt) Composições de aminoácidos e utilidades das mesmas em nutrição clinica
RU94041224A (ru) Пептиды с органозащитной активностью, фармацевтическая композиция на их основе и их применение в терапии
DE69728914D1 (de) Pharmazeutische Zusammensetzung gegen durch Papillomaviren verursachte Tumoren und Infektionen
SE9403526D0 (sv) New Peptides
TR200103339T2 (tr) Geliştirilmiş çözülürlük özelliklerine sahip yeni LHRH-antagonistleri.
RU97105374A (ru) Модифицированные белки
ATE193022T1 (de) Heparin-und sulfatid-bindende peptide vom typ 1 der wiederkehrenden sequenzen vom menschlichen thrombospondin
NO934320D0 (no) T celle reseptor peptider som terapeutiske midler for immun-relaterte sykdommer
SE9603468D0 (sv) New compounds
SE9501067D0 (sv) New peptides
SE9603466D0 (sv) New compounds
BG97123A (bg) Производни на човешка, стимулирана от жлъчните соли, липаза и фармацевтични състави на тяхна основа
DK0707473T3 (da) Orale farmaceutiske præparater omfattende et protein eller et peptid, et antistof og polymerkugler
DK1538162T3 (da) Sammensætninger til ændring af slimsekretion
DE69028783D1 (de) Künstliche peptide, die die zellbindung steigern
SE9603461D0 (sv) New compounds
SE9603463D0 (sv) New compounds
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
SE9603462D0 (sv) New compounds